Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 22, 2020

SELL
$32.47 - $48.83 $142,543 - $214,363
-4,390 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$42.0 - $48.25 $184,380 - $211,817
4,390 New
4,390 $206,000
Q2 2019

Jul 19, 2019

SELL
$39.4 - $42.7 $195,424 - $211,792
-4,960 Closed
0 $0
Q1 2019

May 03, 2019

SELL
$38.57 - $42.69 $108,960 - $120,599
-2,825 Reduced 36.29%
4,960 $207,000
Q4 2018

Feb 07, 2019

BUY
$37.8 - $42.69 $8,316 - $9,391
220 Added 2.91%
7,785 $297,000
Q3 2018

Nov 09, 2018

SELL
$39.75 - $42.69 $16,695 - $17,929
-420 Reduced 5.26%
7,565 $304,000
Q2 2018

Aug 07, 2018

SELL
$39.61 - $42.76 $3,961 - $4,276
-100 Reduced 1.24%
7,985 $322,000
Q1 2018

May 09, 2018

BUY
$36.18 - $40.15 $40,883 - $45,369
1,130 Added 16.25%
8,085 $316,000
Q4 2017

Feb 09, 2018

BUY
$35.34 - $41.9 $245,789 - $291,414
6,955
6,955 $261,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Lex Aurum Advisors, LLC Portfolio

Follow Lex Aurum Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lex Aurum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lex Aurum Advisors, LLC with notifications on news.